Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Activated K-Ras protein accelerates human MLL/AF4-induced leukemo-lymphomogenicity in a transgenic mouse model.

× No keyword cloud information.

27 in total

1. MLL-AF4 driven leukemogenesis: what are we missing?

Authors: Ronald W Stam
Journal: Cell Res Date: 2012-01-31 Impact factor: 25.617

Review 2. Two decades of leukemia oncoprotein epistasis: the MLL1 paradigm for epigenetic deregulation in leukemia.

Authors: Bin E Li; Patricia Ernst
Journal: Exp Hematol Date: 2014-09-28 Impact factor: 3.084

3. Mechanisms of mixed-lineage leukemia.

Authors: Andrew G Muntean
Journal: Int J Hematol Oncol Date: 2013-06-01

4. Inhibition of MEK and ATR is effective in a B-cell acute lymphoblastic leukemia model driven by Mll-Af4 and activated Ras.

Authors: S Haihua Chu; Evelyn J Song; Jonathan R Chabon; Janna Minehart; Chloe N Matovina; Jessica L Makofske; Elizabeth S Frank; Kenneth Ross; Richard P Koche; Zhaohui Feng; Haiming Xu; Andrei Krivtsov; Andre Nussenzweig; Scott A Armstrong
Journal: Blood Adv Date: 2018-10-09

Review 5. Revisiting the biology of infant t(4;11)/MLL-AF4+ B-cell acute lymphoblastic leukemia.

Authors: Alejandra Sanjuan-Pla; Clara Bueno; Cristina Prieto; Pamela Acha; Ronald W Stam; Rolf Marschalek; Pablo Menéndez
Journal: Blood Date: 2015-10-13 Impact factor: 22.113

6. Constitutive Ras signaling and Ink4a/Arf inactivation cooperate during the development of B-ALL in mice.

Authors: Tomasz Sewastianik; Meng Jiang; Kumar Sukhdeo; Sanjay S Patel; Kathryn Roberts; Yue Kang; Ahmad Alduaij; Peter S Dennis; Brian Lawney; Ruiyang Liu; Zeyuan Song; Jessie Xiong; Yunyu Zhang; Madeleine E Lemieux; Geraldine S Pinkus; Jeremy N Rich; David M Weinstock; Charles G Mullighan; Norman E Sharpless; Ruben D Carrasco
Journal: Blood Adv Date: 2017-11-21

Activated K-Ras protein accelerates human MLL/AF4-induced leukemo-lymphomogenicity in a transgenic mouse model.

1. MLL-AF4 driven leukemogenesis: what are we missing?

Review 2. Two decades of leukemia oncoprotein epistasis: the MLL1 paradigm for epigenetic deregulation in leukemia.

3. Mechanisms of mixed-lineage leukemia.

4. Inhibition of MEK and ATR is effective in a B-cell acute lymphoblastic leukemia model driven by Mll-Af4 and activated Ras.

Review 5. Revisiting the biology of infant t(4;11)/MLL-AF4+ B-cell acute lymphoblastic leukemia.

6. Constitutive Ras signaling and Ink4a/Arf inactivation cooperate during the development of B-ALL in mice.

Review 7. Mouse models of MLL leukemia: recapitulating the human disease.

8. Frequencies and prognostic impact of RAS mutations in MLL-rearranged acute lymphoblastic leukemia in infants.

Review 9. Animal models of leukemia: any closer to the real thing?

10. Molecular and Epigenetic Mechanisms of MLL in Human Leukemogenesis.